A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
Titel:
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
Auteur:
Doebele, R.C. Conkling, P. Traynor, A.M. Otterson, G.A. Zhao, Y. Wind, S. Stopfer, P. Kaiser, R. Camidge, D.R.